arrow
P

Peter G. Kremsner

Centre de Recherche Médicales de Lambaréné
H指数:95
被引数:3.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gut resilience and clinical homeostasis following administration of neomycin and albendazole in soil-transmitted helminth-infected adults living in Lambaréné, Gabon

土壤传播蠕虫感染成人接受新霉素和阿苯达唑治疗后肠道韧性与临床稳态的变化

2026-10-030
OA
The human gut microbiome primes fever after vaccination

疫苗接种后人体肠道微生物组对发热的诱导作用

Science
IF45.8
2026-01-010
PRE
Molecular-based assessment of the efficacy of anthelminthic combination regimens for the treatment of Strongyloides stercoralis in Gabon

基于分子方法的抗蠕虫联合方案对加蓬Strongyloides stercoralis治疗有效性的评估

2025-12-090
OA
IgM, IgG, and IgG Subclass Antibody Responses to Plasmodium falciparum Proteins in Naïve, Malaria-Vaccinated and Semi-Immune Volunteers after Controlled Human Malaria Infection
2025-12-010
PRE
Efficacy of Praziquantel for Treatment of Plasmodium falciparum Infection in Asymptomatic Gabonese Adults: A Double-Blind Placebo-Controlled Randomized Trial

吡喹酮治疗无症状加蓬成人恶性疟原虫感染的效果:一项双盲、安慰剂对照随机试验

2025-11-010
OAAI
Making the most of existing antimalarial medicines: a single dose cure with sulfadoxine-pyrimethamine plus artesunate-pyronaridine

最大限度地利用现有抗疟药物:一种含磺胺多辛-乙胺嘧啶联合青蒿素-吡咯萘啶的单剂量治疗方案

2025-09-300
OAAI
Effect of controlled human Plasmodium falciparum infection on B cell subsets in individuals with different levels of malaria immunity

控制性人类恶性疟原虫感染对不同疟疾免疫水平个体B细胞亚群的影响

2025-09-270
OAAI
Safety, tolerability, and protective efficacy of a radiation-attenuated, whole sporozoite malaria vaccine in children in Gabon: a randomised, double-blind, placebo-controlled, phase 2 trial

在加蓬儿童中评估一种辐射致弱的全子孢子疟疾疫苗的安全性、耐受性及保护效力:一项随机、双盲、安慰剂对照的2期试验

2025-09-160
OAAI
Causative Pathogens and Predictors of Unfavourable Outcomes in Central Nervous System Infections in Resource-Limited Settings

致病病原体及在资源有限环境下中枢神经系统感染不良预后的预测因素

2025-08-050
OAAI
Class switch towards IgG2 and IgG4 is more pronounced in BNT162b2 compared to mRNA-1273 COVID-19 vaccinees

与mRNA-1273 COVID-19疫苗受种者相比,BNT162b2疫苗受种者中向IgG2和IgG4的类别转换更为显著。

2025-07-170
OAAI
Which trial do we need? A randomised controlled study to compare the protective efficacy of early post-exposure discontinuation versus standard atovaquone-proguanil malaria prophylaxis in a human Plasmodium falciparum challenge model

我们需要哪种试验?一项随机对照研究,比较在人类恶性疟原虫挑战模型中,早期暴露后中断用药与标准阿托喹酮-氯胍疟疾预防措施的保护效果。

2025-04-260
PRE
Broadening the Healthy Aging Paradigm: Inclusion of Gestation, Development, and Reproductive Health

扩大健康老龄化范式: 包括妊娠,发育和生殖健康

2025-02-140
PRE
Immune responses to SARS-CoV-2 in sub-Saharan Africa and western Europe: a retrospective, population-based, cross-sectional study

撒哈拉以南非洲和西欧地区对SARS-CoV-2的免疫反应:一项回顾性、基于人群的横断面研究

2025-02-011
OAAI